NASDAQ:NIKI | Cash Flow Statement | Niki BioSolutions, Inc.

Complete source-backed cash-flow history.

Available history
2018-12-31 to 2025-12-31
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$307,495.00-$535,719.00$1.72M
2024-12-31-$919,900.00$119,646.00$0.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$1.36M-$1.84M$4.42M
2024-12-31-$4.27M-$1.19M$58,621.00
2023-12-31-$2.82M$1.13M-$7.72M$3,015.00$624,767.00$4.09M
2022-12-31-$9.8M$1.21M-$12.32M$186,916.00$2.44M$6.63M
2021-12-31-$25.05M$1.19M-$14.65M$131,750.00$16.51M$2.78M
2020-12-31$4.92M$1.33M-$15.93M$161,314.00$1.84M$12.42M
2019-12-31-$20.12M$1.3M-$13.38M$837,062.00-$108,061.00-$7.32M
2018-12-31-$14.83M$682,292.00-$10.04M$5.65M-$6.06M$25.48M